From : Vinay Dixit <Vinay.d@heterodrugs.com>
To : Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Subject : RE: Request from MoH Georgia regarding procuring Remdesivir
Cc : Pranjali Singh Chauhan <PranjaliSingh.C@heterodrugs.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; Ekaterine Adamia <eadamia@moh.gov.ge>; Alisa Tsuladze <atsuladze@moh.gov.ge>
Received On : 13.10.2020 14:01
Attachments :
Dear Maia Madam, Please find : 1. Manufacturing certificate (Domestic and Export) 2. Free Sales Certificate (Domestic and Export) 3. Relationship letter Hetero and Aspiro 4. Gilead - Hetero confidential agreement for Remdesivir. 5. Artworks of COVIFOR (Remdesivir) Please kindly send your Purchase Order on your letter head with sign and signatures. So as to initiate production and planning of shipment. Contract will follow. Thanks & Regards, Vinay Dixit General Manager - CIS Countries +91 9100 109 463 Hetero Labs Limited Vinay.d@heterodrugs.com 7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad - 500018, Telangana, India. Tel: +91 040 23704923 Ext No: 3138 www.heteroworld.com | -----Original Message----- From: Maia Nikoleishvili Sent: 08 October 2020 00:07 To: Vinay Dixit Cc: Pranjali Singh Chauhan ; Tamar Gabunia ; Ekaterine Adamia ; Alisa Tsuladze Subject: Re: Request from MoH Georgia regarding procuring Remdesivir Dear Mr. Vinay, Many thanks for your prompt reply. Based on our negotiations through WhatsApp, I would like to kindly share with my colleagues the revised price of Remdesivir, which amounts to 32 Euro per vial, CIP Tbilisi. Total amount is 96 000 Euro for 3000 vial (6 vial for each patient). Would you be kind to confirm the revised price? Thank you once again for your support and fruitful collaboration. Best regards, Maia > On 7 Oct 2020, at 19:38, Vinay Dixit wrote: > > Payment terms: 50% advance with purchase order and 50% before shipment. Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please delete the message and any attachments from your Inbox.